HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Escherichia coli endotoxin

Subscribe to New Research on Escherichia coli endotoxin

Also Known As:

endotoxin, Escherichia coli; E coli endotoxin 0111-B4; endotoxin, E coli 026-B8; endotoxin, E coli O127-B8; endotoxin, Escherichia coli 0111-B4; lipopolysaccharide, E coli O8; lipopolysaccharide, E coli O9

Networked: 398 relevant articles (2 outcomes, 37 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Biological Factors: 1315
- Biological Toxins: 13
  - Bacterial Toxins: 407
    - Endotoxins: 937
      - Escherichia coli endotoxin: 398

Experts

1.	Wolzt, Michael: 6 articles (07/2013 - 09/2002)
2.	Buduneli, Eralp: 6 articles (10/2008 - 11/2004)
3.	Buduneli, Nurcan: 6 articles (10/2008 - 11/2004)
4.	Atilla, Gül: 6 articles (10/2008 - 11/2004)
5.	van der Hoeven, Johannes G: 3 articles (05/2014 - 02/2009)
6.	Pickkers, Peter: 3 articles (05/2014 - 02/2009)
7.	Baylas, Haluk: 3 articles (10/2008 - 01/2005)
8.	Ishizaka, Akitoshi: 3 articles (01/2008 - 08/2003)
9.	Tasaka, Sadatomo: 3 articles (01/2008 - 08/2003)
10.	Yamaguchi, Kazuhiro: 3 articles (01/2008 - 08/2003)

Related Diseases

1.	Inflammation 05/01/1999 - "The administration of reference endotoxin (Escherichia coli O:113, Lot EC-5) to humans has been an important means to study inflammation in vivo; however, the supply of Lot EC-5 is depleted. " 03/01/2008 - "Inflammation was induced by continuous infusion of Escherichia coli endotoxin (lipopolysaccharide, LPS). " 10/01/2006 - "We administered 2 ng/kg endotoxin [Escherichia coli bacterial lipopolysaccharide (LPS)] intravenously to stimulate inflammation in 91 healthy young Caucasian male paid volunteers (age range, 19-40 years). " 01/01/2002 - "Escherichia coli endotoxin infusions resulted in a considerable decrease in the size of the ovaries, and morphological changes characteristic for acute and chronic inflammation were observed." 08/01/1982 - "Effect of Escherichia coli endotoxin-mediated inflammation of one mammary quarter of the bovine udder on diapedesis into other quarters."
2.	Endotoxemia 06/01/1988 - "We tested the hypothesis that endotoxemia might produce a similar defect in the efficacy of tissue O2 extraction by determining the whole-body critical systemic QO2 (QO2 c) and critical extraction ratio in a control group of dogs and a group receiving a 5-mg/kg dose of Escherichia coli endotoxin. " 07/01/1992 - "Endotoxemia was induced in five range ewes (41 +/- 2 kg) by continuous infusion of Escherichia coli endotoxin (LPS, 10 ng.kg-1.min-1) over the entire study period. " 06/01/1984 - "To study the effect of low-grade continuous endotoxemia in normal and cirrhotic dogs, osmotic minipumps were filled with Escherichia coli endotoxin, implanted subcutaneously and arranged so that the endotoxin could be infused intravenously over a 7-day period in doses ranging from 2.5 to 100 micrograms/h. " 04/01/1983 - "To study the effects of endotoxemia on hepatic mitochondrial function and nutrient blood flow, rats were given intraperitoneal Escherichia coli endotoxin at a lethal dose for 90% mortality of group. " 05/20/2014 - "Subsequently, all subjects underwent experimental endotoxemia (i.v. administration of 2 ng/kg Escherichia coli endotoxin). "
3.	Septic Shock (Toxic Shock Syndrome) 11/01/2012 - "The lipopolysaccharide and continuous blood purification/lipopolysaccharide groups were injected intravenously with Escherichia coli endotoxin to induce septic shock. " 08/01/2004 - "Endotoxic shock was induced by a single lipopolysaccharide (LPS, serotype O55:B5) bolus (0.5 mg.kg(-1), i.v., Escherichia coli endotoxin). " 05/01/2002 - "Endotoxic shock was induced by administration of Escherichia coli endotoxin in rats. " 11/01/2000 - "Endotoxic shock was induced by a single lipopolysaccharide bolus (0.5 mg/kg i.v., Escherichia coli endotoxin). " 10/01/1997 - "The rats (n = 111) were anesthetized and were injected with 15 mg/kg of Escherichia coli endotoxin (lipopolysaccharide, LPS) intravenously to produce septic shock. "
4.	Body Weight (Weight, Body) 01/01/2013 - "20 male healthy subjects received a single intravenous bolus of 2 ng/kg body weight Escherichia coli endotoxin (LPS). " 10/01/2001 - "At 2 h after the start of the infusions Escherichia coli endotoxin O26:B6 (2 microg/kg body weight) was intravenously injected. " 02/01/1998 - "Male Wistar rats (200-250 g body weight) were injected intraperitoneally with endotoxin (Escherichia coli, 055 B5) dissolved in sterile normal saline [250 microg/kg first group, 2.5 mg/kg (second group) and 6.25 mg/kg (third group)] in a final volume of 0.5 ml, or saline alone in the control group. " 07/01/1991 - "Escherichia coli endotoxin (055:B5) was infused IV at a rate of 0.1 microgram/kg of body weight over 30 minutes. " 03/15/1988 - "Endotoxin (Escherichia coli) from 25 ug to 100 ug/100g body weight was administered intravenously. "
5.	Shock 07/01/2000 - "This study assessed the effects of rapid (10 microg/kg over 5 min) and slow (10 microg/kg over 60 min) induction of endotoxin (Escherichia coli) shock on splanchnic blood volume in 8 farm swine. " 06/01/1981 - "Atrial muscle isolated from guinea pigs subjected to Escherichia coli endotoxin shock was used to study the myocardial changes associated with this experimental disease state. " 01/01/1979 - "Atrial myocardium of guinea pigs was used to study effects of Escherichia coli endotoxin shock on inotropic characteristics of heart muscle free from noncardiac influences of the in vivo shock state. " 10/01/1995 - "We studied the absolute and temporal changes in HR power spectra and plasma catecholamine concentrations in eight experimental and six control New Zealand white rabbits during Escherichia coli endotoxin-induced shock. " 01/01/1991 - "Twelve animals underwent acute circulatory shock induced by intravenous Escherichia coli endotoxin 0.5 mg/kg. Four control dogs received normal saline. "

Related Drugs and Biologics

1.	Interleukin-10 (Interleukin 10)
2.	Alendronate (Alendronate Sodium)
3.	Doxycycline (Vibramycin)
4.	Gentamicins (Gentamicin)
5.	Zymosan
6.	Dacarbazine (DIC)
7.	antineoplaston A10 (A 10)
8.	Epoprostenol (Prostacyclin)
9.	Nitroglycerin (Dynamite)
10.	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

Related Therapies and Procedures

1.	Intravitreal Injections
2.	Intravenous Infusions
3.	Intravenous Injections
4.	Intraperitoneal Injections
5.	General Anesthesia